NextCure  Inc (NXTC)

Currency in USD
6.630
+0.050(+0.76%)
Closed·
6.242-0.388(-5.85%)
·
Advertisement

NextCure (NXTC) Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy

Technical Indicators

Strong Buy

Moving Averages

Strong Buy

Summary:Strong Buy

Moving Averages:Strong BuyBuy: (12)Sell: (0)
Technical Indicators:Strong BuyBuy: (6)Sell: (2)

Technical Indicators

Summary: Strong BuyBuy: 6Neutral: 2Sell: 2
Jul 15, 2026 22:45 GMT
Name
Value
Action
RSI(14)69.299Buy
STOCH(9,6)29.5Sell
STOCHRSI(14)20.471Oversold
MACD(12,26)0.873Buy
ADX(14)28.524Buy
Williams %R-71.22Sell
CCI(14)42.3599Neutral
ATR(14)1.2489High Volatility
Highs/Lows(14)0Neutral
Ultimate Oscillator54.901Buy
ROC204.128Buy
Bull/Bear Power(13)1.308Buy

Moving Averages

Summary: Strong BuyBuy: 12Sell: 0
Jul 15, 2026 22:45 GMT
Name
Simple
Exponential
MA5
6.005
Buy
6.134
Buy
MA10
6.099
Buy
5.796
Buy
MA20
5.038
Buy
5.151
Buy
MA50
3.135
Buy
3.763
Buy
MA100
2.456
Buy
3.012
Buy
MA200
2.403
Buy
3.514
Buy

Pivot Points

Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic5.4165.5485.7065.8385.9966.1286.286
Fibonacci5.5485.6595.7275.8385.9496.0176.128
Camarilla5.7855.8125.8385.8385.8925.9185.945
Woodie's5.435.5555.725.8456.016.1356.3
DeMark's--5.7735.8716.063--

FAQ

Is NextCure (NXTC) a Buy or Sell, from a Technical Analysis Perspective?

Based on moving averages and other technical indicators, today's NextCure buy/sell signal is Strong Buy.

What Do The Current Moving Averages for NextCure (NXTC) Show?

The moving averages for NextCure show a Buy outlook, considering moving averages ranging from MA5 to MA200, with 8 Buy signals and 4 Sell signals.

What Do Today's Technical Indicators for NextCure Show?

The technical indicators for NextCure are in a Strong Buy position based on daily analysis, with 6 signals on buy indicators and 2 sell signals.

What Is NextCure (NXTC)'s 14-Day RSI?

The current Relative Strength Index (RSI) of NXTC over the 14-day period is 69.299, which suggests that the stock is a Buy.

What Is NextCure (NXTC)'s MACD?

NXTC's MACD (Moving Average Convergence/Divergence) is 0.873, which suggests that the stock is a Buy.

What Is NextCure (NXTC)'s 5-Day Moving Average?

NXTC's 5-day moving average is 6.005, suggesting that the stock is a Buy.

What Is NextCure (NXTC)'s 50-Day Moving Average?

NXTC's 50-day moving average is 3.135, suggesting that the stock is a Buy.

What Is NextCure (NXTC)'s 200-Day Moving Average?

NXTC's 200-day moving average is 2.403, suggesting that the stock is a Buy.

What Is the Fibonacci Pivot Point Performance Value for NextCure (NXTC)?

The Fibonacci pivot point performance value for NXTC is 5.838.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.